Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase

John T. Durkin, Seetha Murthy, E. Jean Husten, Stephen P. Trusko, Mary J. Savage, David Rotella, Barry D. Greenberg, Robert Siman

Research output: Contribution to journalArticleResearchpeer-review

44 Citations (Scopus)

Abstract

The Alzheimer's disease amyloid peptide Aβ has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells. The proteolytic activity that liberates the Aβ COOH terminus from the β-amyloid precursor protein is called γ-secretase. It could be one protease with dual specificity or two distinct enzymes. By using enzyme-linked immunosorbent assays selective for Aβ40 or Aβ42, we have measured Aβ secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse γ- secretase inhibitors. The inhibitors lowered Aβ and p3 secretion and increased levels of the COOH-terminal 99-residue β-amyloid precursor protein derivative that is the precursor for Aβ but did not alter secretion of β- amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the γ-secretase processing step. The dose-dependent inhibition of Aβ42 was unusual, as the compounds elevated Aβ42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses. A compound was identified that elevated Aβ42 secretion at a low concentration without inhibiting Aβ42 or Aβ40 at high concentrations, demonstrating that these phenomena are separable pharmacologically. Using either of two methods, IC50 values for inhibition of Aβ42 and Aβ40 were found to have the same rank-order and fall on a trend line with near-unit slope. These results favor the hypothesis that Aβ variants ending at residue 40 or 42 are generated by a single γ-secretase.

Original languageEnglish
Pages (from-to)20499-20504
Number of pages6
JournalJournal of Biological Chemistry
Volume274
Issue number29
DOIs
StatePublished - 16 Jul 1999

Fingerprint

Amyloid Precursor Protein Secretases
Amyloid beta-Protein Precursor
Cells
Derivatives
Immunosorbents
Amyloid Plaques
Enzymes
HeLa Cells
Amyloid
Inhibitory Concentration 50
Cultured Cells
Assays
Alzheimer Disease
Peptide Hydrolases
Enzyme-Linked Immunosorbent Assay
Inhibition (Psychology)
Cell Line
Processing

Cite this

Durkin, John T. ; Murthy, Seetha ; Husten, E. Jean ; Trusko, Stephen P. ; Savage, Mary J. ; Rotella, David ; Greenberg, Barry D. ; Siman, Robert. / Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 29. pp. 20499-20504.
@article{85d34818e2c246aea0137c811e28df26,
title = "Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase",
abstract = "The Alzheimer's disease amyloid peptide Aβ has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells. The proteolytic activity that liberates the Aβ COOH terminus from the β-amyloid precursor protein is called γ-secretase. It could be one protease with dual specificity or two distinct enzymes. By using enzyme-linked immunosorbent assays selective for Aβ40 or Aβ42, we have measured Aβ secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse γ- secretase inhibitors. The inhibitors lowered Aβ and p3 secretion and increased levels of the COOH-terminal 99-residue β-amyloid precursor protein derivative that is the precursor for Aβ but did not alter secretion of β- amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the γ-secretase processing step. The dose-dependent inhibition of Aβ42 was unusual, as the compounds elevated Aβ42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses. A compound was identified that elevated Aβ42 secretion at a low concentration without inhibiting Aβ42 or Aβ40 at high concentrations, demonstrating that these phenomena are separable pharmacologically. Using either of two methods, IC50 values for inhibition of Aβ42 and Aβ40 were found to have the same rank-order and fall on a trend line with near-unit slope. These results favor the hypothesis that Aβ variants ending at residue 40 or 42 are generated by a single γ-secretase.",
author = "Durkin, {John T.} and Seetha Murthy and Husten, {E. Jean} and Trusko, {Stephen P.} and Savage, {Mary J.} and David Rotella and Greenberg, {Barry D.} and Robert Siman",
year = "1999",
month = "7",
day = "16",
doi = "10.1074/jbc.274.29.20499",
language = "English",
volume = "274",
pages = "20499--20504",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "29",

}

Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase. / Durkin, John T.; Murthy, Seetha; Husten, E. Jean; Trusko, Stephen P.; Savage, Mary J.; Rotella, David; Greenberg, Barry D.; Siman, Robert.

In: Journal of Biological Chemistry, Vol. 274, No. 29, 16.07.1999, p. 20499-20504.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Rank-order of potencies for inhibition of the secretion of Aβ40 and Aβ42 suggests that both are generated by a single γ-secretase

AU - Durkin, John T.

AU - Murthy, Seetha

AU - Husten, E. Jean

AU - Trusko, Stephen P.

AU - Savage, Mary J.

AU - Rotella, David

AU - Greenberg, Barry D.

AU - Siman, Robert

PY - 1999/7/16

Y1 - 1999/7/16

N2 - The Alzheimer's disease amyloid peptide Aβ has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells. The proteolytic activity that liberates the Aβ COOH terminus from the β-amyloid precursor protein is called γ-secretase. It could be one protease with dual specificity or two distinct enzymes. By using enzyme-linked immunosorbent assays selective for Aβ40 or Aβ42, we have measured Aβ secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse γ- secretase inhibitors. The inhibitors lowered Aβ and p3 secretion and increased levels of the COOH-terminal 99-residue β-amyloid precursor protein derivative that is the precursor for Aβ but did not alter secretion of β- amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the γ-secretase processing step. The dose-dependent inhibition of Aβ42 was unusual, as the compounds elevated Aβ42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses. A compound was identified that elevated Aβ42 secretion at a low concentration without inhibiting Aβ42 or Aβ40 at high concentrations, demonstrating that these phenomena are separable pharmacologically. Using either of two methods, IC50 values for inhibition of Aβ42 and Aβ40 were found to have the same rank-order and fall on a trend line with near-unit slope. These results favor the hypothesis that Aβ variants ending at residue 40 or 42 are generated by a single γ-secretase.

AB - The Alzheimer's disease amyloid peptide Aβ has a heterogeneous COOH terminus, as variants 40 and 42 residues long are found in neuritic plaques and are secreted constitutively by cultured cells. The proteolytic activity that liberates the Aβ COOH terminus from the β-amyloid precursor protein is called γ-secretase. It could be one protease with dual specificity or two distinct enzymes. By using enzyme-linked immunosorbent assays selective for Aβ40 or Aβ42, we have measured Aβ secretion by a HeLa cell line, and we have examined the dose responses for a panel of five structurally diverse γ- secretase inhibitors. The inhibitors lowered Aβ and p3 secretion and increased levels of the COOH-terminal 99-residue β-amyloid precursor protein derivative that is the precursor for Aβ but did not alter secretion of β- amyloid precursor protein derivatives generated by other secretases, indicating that the inhibitors blocked the γ-secretase processing step. The dose-dependent inhibition of Aβ42 was unusual, as the compounds elevated Aβ42 secretion at sub-inhibitory doses and then inhibited secretion at higher doses. A compound was identified that elevated Aβ42 secretion at a low concentration without inhibiting Aβ42 or Aβ40 at high concentrations, demonstrating that these phenomena are separable pharmacologically. Using either of two methods, IC50 values for inhibition of Aβ42 and Aβ40 were found to have the same rank-order and fall on a trend line with near-unit slope. These results favor the hypothesis that Aβ variants ending at residue 40 or 42 are generated by a single γ-secretase.

UR - http://www.scopus.com/inward/record.url?scp=0033575224&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.29.20499

DO - 10.1074/jbc.274.29.20499

M3 - Article

VL - 274

SP - 20499

EP - 20504

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 29

ER -